Asia Pacific Endovenous Laser Therapy Market

APAC Endovenous Laser Therapy Market Size (2023 to 2028)

The size of the Asia Pacific Endovenous Laser Therapy market was around USD 54.66 million in 2023. It is expected to grow at a CAGR of 7.9% to reach USD 79.95 million by 2028. It captures 20% of the global market.

The APAC endovenous laser therapy market has seen significant progress, owing to ongoing advancements in the techniques utilized in the field. Due to the increased incidence of varicose veins, the APAC endovenous laser therapy market is likely to grow over the forecast period. Obesity's rising prevalence is predicted to promote market growth further. Adopting developing technologies due to technological innovation catalyzes business development; the endovenous laser systems market is expected to expand in revenue as the population ages.

Increased R&D in ELT (endovenous laser treatment) and ELA (endovenous laser ablation) is projected to help the APAC endovenous laser therapy market grow. According to researchers from the Azerbaijan State Advanced Training Institute for Doctors, ELA is a safe, reliable, and less painful way of ablating inadequate perforated veins that may be performed as an outpatient treatment.

The utilization of suitable strategies to decrease postoperative problems in inpatient groups is critical to the success of EVLT. As a result, inventors of endovenous laser systems and ablation technologies are constantly improving their methods. This is an integral part of the endovenous laser treatment market's evolution.

The availability of alternative therapies is expected to restrict the APAC endovenous laser therapy market. For instance, the 'VenaSeal Closure System' treats varicose veins by closing the problematic vein closest to the skin (superficial varicose veins). The approach also reduces the possibility of nerve injury produced by thermal-based methods because it is non-sclerosant, non-thermal, and non-tumescent. High beginning expenses may further limit the market's expansion. Risk considerations connected with varicose vein treatment and a scarcity of highly experienced practitioners may also restrain the market. The market expansion is also likely to be impeded by ELT-related challenges. Skin burns, deep vein thrombosis, pulmonary embolism, nerve damage, transient numbness, bruising, phlebitis, hemorrhage, induration, and a tightness sensation are only some of the dangers associated with endovenous laser treatment.

This research report on the APAC endovenous laser therapy market has been segmented and sub-segmented into the following categories.

By Technology:

• Endovenous Laser Systems             
  • Diode Lasers
  • YAG Lasers
• Endovenous Laser Fibres  
  • Bare Tip Laser Fibre
  • Radial Tip Laser Fibre
  • Gold Tip Laser Fibre

By End User:

• Hospital   
• Clinic         
• Ambulatory Centre        

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the surge in demand for varicose veins treatment procedures owing to the increasing number of patients suffering from varicose veins in China is anticipated to result in increasing adoption of Endovenous laser systems in China, thereby adding to the market attractiveness of this segment in the country and subsequently in the APEJ region. Furthermore, due to a rise in disposable income, improved healthcare infrastructure, increasing patient knowledge about the benefits of seeking early treatment, and fast expansion in the aging population, the APAC Endovenous Laser Therapy Market is expected to develop rapidly in the near future.

During the forecast period, China is forecasted to dominate the APAC Endovenous Laser Therapy Market. The rising demand for varicose vein treatment operations in China, owing to the growing number of patients with varicose veins, is expected to boost the adoption of Endovenous laser systems, boosting the market attractiveness of this category in the nation.

After China, Japan holds the largest share of the Asia Pacific Endovenous Laser Therapy Market. The government has endorsed EVLTs for patient populations because of their safety and better patient comfort. This is expected to help the endovenous laser treatment market grow at a much steadier pace.

KEY MARKET PLAYERS:

Companies playing a pivotal role in the APAC endovenous laser therapy market are Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, AngioDynamics, Inc., Syneron Medical Ltd, Dornier Medtech GmbH, Wontech Co., Ltd, intros Medical Laser GmbH, Energist Ltd, among others.